Your browser doesn't support javascript.
loading
B7-H4 is increased in lung adenocarcinoma harboring EGFR-activating mutations and contributes to immunosuppression.
Lu, Youwei; Wu, Fengying; Cao, Qiuyi; Sun, Yu; Huang, Moli; Xiao, Jing; Zhou, Bin; Zhang, Liang.
Afiliação
  • Lu Y; College of Pharmaceutical Sciences, Soochow University, Suzhou, Jiangsu, China.
  • Wu F; Department of Medical Oncology, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, China.
  • Cao Q; College of Pharmaceutical Sciences, Soochow University, Suzhou, Jiangsu, China.
  • Sun Y; College of Pharmaceutical Sciences, Soochow University, Suzhou, Jiangsu, China.
  • Huang M; Department of Bioinformatics, School of Biology & Basic Medical Sciences, Soochow University, Suzhou, China.
  • Xiao J; Central Laboratory, Songgang People's Hospital of Shenzhen Baoan District, Shenzhen, Guangdong, China.
  • Zhou B; Jiangsu Institute of Clinical Immunology, The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu, China. karichou@163.com.
  • Zhang L; Jiangsu Key Laboratory of Clinical Immunology, Soochow University, Suzhou, Jiangsu, China. karichou@163.com.
Oncogene ; 41(5): 704-717, 2022 01.
Article em En | MEDLINE | ID: mdl-34839353
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fosfatidilinositol 3-Quinases Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fosfatidilinositol 3-Quinases Idioma: En Ano de publicação: 2022 Tipo de documento: Article